Fitzgerald PJFrom Demons and Evil Spirits to Cancer Genes: the Development of Concepts Concerning the Causes of Cancer and Carcinogenesis. Washington, DC: American Registry of Pathology, Armed Forces Institute of Pathology; 2000.
Watson JD, Crick FHMolecular structure of nucleic acids. A structure for deoxyribose nucleic acid. Nature. 1953; 171(4356):737-738.
4.
Watson JD, Crick FHGenetic implications of the structure of deoxyribonucleic acid. Nature. 1953;171(4361):964-967.
5.
Nirenberg MWProtein synthesis and the RNA code. Harvey Lectures Series. 1964;59:155-185.
6.
Tjio J.-H, Levan A.The chromosome number of man. Hereditas. 1956 ;42:1-6.
7.
Arnason U.50 years after-examination of some circumstances around the establishment of the correct chromosome number of man. Hereditas. 2006;143(2006):202-211.
8.
Nowell PC, Hungerford DAA minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497.
9.
Todaro GJ, Huebner RJThe viral oncogene hypothesis: new evidence. Proc Nat Acad Sci U S A. 1972;69(4):1009-1015.
10.
Bishop JMThe molecular genetics of cancer. Science. 1987;235(4786):305-311.
11.
Venter J., Adams M., Myers E., et al. (274 co-authors). 2001. The sequence of the human genome. Science. 2001;291(5507):1304-1351 [Erratum in: Science. 2001;292(5523):1838].
12.
International Human Genome Sequencing Consortium.Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921 [Erratum in: Nature. 2001;412(6846):565 and Nature. 2001;411(6838):720].
13.
Shuper A., Stark B., Kornreich L., et al. Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity. J Child Neurol . 2000;15(9):573-580.
14.
Camfield CS , Camfield PR, Gordon K., Wirrell E., Dooley JMIncidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996; 37(1):19-23.
15.
Martins AMInborn errors of metabolism: a clinical overview. Sao Paulo Med J/Rev Paul Med. 1999;117(6):251-265.
16.
Fangusaro J. , Chi S.Introduction to a special issue on pediatric neuro-oncology. J Child Neurol.2009;24(11):1341-1342.
17.
Lunn MR, Wang CHSpinal muscular atrophy. Lancet. 2008;371(9630):2120-2133.
18.
Kostova FV, Williams VC, Heemskerk J., et al. Spinal muscular atrophy: classification, diagnosis, management, pathogenesis, and future research directions. J Child Neurol . 2007;22(8): 926-945.
Swoboda KJ, Kissel JT, Crawford TO, et al. Perspectives on clinical trials in spinal muscular atrophy. J Child Neurol. 2007;22(8):957-966.
22.
Shanmugarajan S., Swoboda KJ, Iannaccone ST, et al. Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. J Child Neurol. 2007;22(8): 967-973.
Kolb SJ, Battle DJ, Dreyfuss G.Molecular functions of the SMN complex. J Child Neurol. 2007;22(8):990-994.
26.
Beattie CE, Carrel TL, McWhorter MLFishing for a mechanism: using zebrafish to understand spinal muscular atrophy . J Child Neurol. 2007;22(8):995-1003.
27.
Schmid A., DiDonato CJAnimal models of spinal muscular atrophy. J Child Neurol. 2007;22(8):1004-1012.
28.
Heier CR, Gogliotti RG, DiDonato CJSMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy? J Child Neurol . 2007;22(8):1013-1018.
29.
Meldrum C., Scott C., Swoboda KJSpinal muscular atrophy genetic counseling access and genetic knowledge: parents’ perspectives. J Child Neurol. 2007;22(8):1019-1026.
30.
Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027-1049.
31.
Cohen ME, Duffner PKBrain Tumors in Children: Principles of Diagnosis and Treatment. New York: Raven Press; 1984.
32.
Babcock MA, Kostova FV, Guha A., et al. Tumors of the central nervous system: clinical aspects, molecular mechanisms, unanswered questions, and future research directions. J Child Neurol. 2008;23(10):1103-1121.
Becher OJ, Peterson KM, Khatua S., Santi MR, MacDonald TJIGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK. J Child Neurol. 2008 ;23(10):1205-1213.
43.
Maria BL, Gupta N., Gilg AG, et al. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas. J Child Neurol. 2008;23(10):1214-1220.
44.
Tye SL, Gilg AG, Tolliver LB, et al. Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors. J Child Neurol. 2008;23(10): 1221-1230.